About
About Zhongzhi Pharmaceutical Holdings Limited
Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People's Republic of China. The company operates through two segments Pharmaceutical Manufacturing and Operation of Chain Pharmacies segments. It also provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brand names. In addition, the company manufactures and sells food and Chinese herbs; offers detection and testing and property management. Further, the company engages in the wholesale of pharmaceutical products; and provision of traditional Chinese medicine service. Zhongzhi Pharmaceutical Holdings Limited was founded in 1993 and is headquartered in Zhongshan, the People's Republic of China. Zhongzhi Pharmaceutical Holdings Limited operates as a subsidiary of Crystal Talent Investment Group Limited.
Visit company website
5 years, 5 months ago
Zhongzhi Pharmaceutical Holdings Limited is currently in a long term downtrend where the price is trading 6.3% below its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.6.
Zhongzhi Pharmaceutical Holdings Limited's total revenue rose by 22.6% to $866M since the same quarter in the previous year.
Its net income has increased by 19.4% to $67M since the same quarter in the previous year.
Finally, its free cash flow grew by 192.2% to $17M since the same quarter in the previous year.
Based on the above factors, Zhongzhi Pharmaceutical Holdings Limited gets an overall score of 4/5.